# Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

> **NCT04748926** · PHASE1 · COMPLETED · sponsor: **Principia Biopharma, a Sanofi Company** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** rilzabrutinib SAR444671
- **DRUG:** rilzabrutinib SAR444671
- **DRUG:** rilzabrutinib SAR444671

## Key facts

- **NCT ID:** NCT04748926
- **Lead sponsor:** Principia Biopharma, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-07
- **Primary completion:** 2021-05-21
- **Final completion:** 2021-05-21
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748926, "Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04748926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*